Return to Clinical Trials Search Results

Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer

Primary Outcome Measures: Local-regional recurrence (LRR) [Time Frame: Up to 5 years] Secondary Outcome Measures: Re-operation rate [Time Frame: Up to 5 years] Conversion rate to mastectomy secondary to persistent positive margins or poor cosmesis [Time Frame: Within the first 6 months] Time to contralateral breast cancer [Time Frame: Up to 5 years post-randomization] Disease-free survival (DFS) [Time Frame: Up to 5 years post-randomization] Overall survival [Time Frame: Up to 5 years post-randomization] Breast cancer specific survival will be measured [Time Frame: Up to 5 years post-randomization] Rate of MRI-guided localization assisted surgery (Arm B) [Time Frame: Up to 5 years] False positive rate for MRI detection of multiple disease foci [Time Frame: Up to 5 years]

Primary Outcome Measures: Local-regional recurrence (LRR) [Time Frame: Up to 5 years] Secondary Outcome Measures: Re-operation rate [Time Frame: Up to 5 years] Conversion rate to mastectomy secondary to persistent positive margins or poor cosmesis [Time Frame: Within the first 6 months] Time to contralateral breast cancer [Time Frame: Up to 5 years post-randomization] Disease-free survival (DFS) [Time Frame: Up to 5 years post-randomization] Overall survival [Time Frame: Up to 5 years post-randomization] Breast cancer specific survival will be measured [Time Frame: Up to 5 years post-randomization] Rate of MRI-guided localization assisted surgery (Arm B) [Time Frame: Up to 5 years] False positive rate for MRI detection of multiple disease foci [Time Frame: Up to 5 years]